Klebsiella pneumoniae is an important human pathogen associated with a variety of diseases, and the prevalence of multidrugresistant K. pneumoniae (MDRKP) is rapidly increasing. Here we determined the capsular types of 85 carbapenem-resistant K. pneumoniae (CRKP) strains by wzc sequencing and investigated the presence of carbapenemases and integrons among CRKP strains. Ten CRKP strains (12%) were positive for carbapenemase (imipenemase, 6/85 strains; K. pneumoniae carbapenemase, 3/85 strains; Verona integron-encoded metallo-␤-lactamase, 1/85 strains). Capsular type K64 accounted for 32 CRKP strains (38%), followed by K62 (13%), K24 (8%), KN2 (7%), and K28 (6%). Sequence types (STs) were determined by multilocus sequence typing (MLST), and the results indicated that ST11, which accounted for 47% of these CRKP strains (40/85 strains), was the major ST. We further isolated a K64-specific capsule depolymerase (K64dep), which could enhance serum and neutrophil killing in vitro and increase survival rates for K64 K. pneumoniae-inoculated mice. The toxicity study demonstrated that mice treated with K64dep showed normal biochemical parameters and no significant histopathological changes of liver, kidney, and spleen, indicating that enzyme treatment did not cause toxicity in mice. Therefore, the findings of capsular type clustering among CRKP strains and effective treatment with capsule depolymerase for MDRKP infections are important for capsule-based vaccine development and therapy.
depolymerase treatments that can help with the prevention and treatment of multidrug-resistant K. pneumoniae (MDRKP) infections. However, previous serotyping studies yielded limited information because only 25% of hospital infection strains can be typed (21) . Recently, a few studies conducted surveys of the capsular types of CRKP by genotyping, and some new capsular types were reported to be predominant in CRKP strains from Italy and from the United States (22) (23) (24) (25) (26) (27) . Here we used a genotyping method as well as phage-depolymerase typing to clarify the prevalence of capsule types in CRKP from Taiwan and developed a depolymerase-based treatment for the prevalent capsular types in CRKP.
MATERIALS AND METHODS
the CD1-VR2-CD2 region were compared with those of reference strains (40) by NCBI nucleotide BLAST, and the corresponding capsular types were determined according to the criteria of Ն94% DNA identity for the same types and Ͻ80% identity for different types, with reconfirmation by wzy PCR for inconclusive results (e.g., K52 and K79 exhibited 89% wzc DNA sequence identity, and K9 and K45 exhibited 99% wzc DNA sequence identity; the strains were distinguished by wzy PCR [40] ). The phylogenetic tree of wzc sequences from reference strains and CRKP strains was generated by the neighbor-joining method using the program MEGA (version 4).
Sequencing of capsular polysaccharide (CPS) synthesis region. The cps regions of the K64 reference strain and the N386 strain (KN3) were amplified as described previously (29) . The products were sequenced by primer walking, providing sequences for the cps regions. Genes were annotated by NCBI BLAST.
wzy PCR genotyping and phage-depolymerase specificity. Primers specific for the wzy gene of K64 were designed for reconfirmation of the strains with K64 wzc type by wzy PCR ( Fig. 1A ; also see Table S1 in the supplemental material). Specific primers for strain KCR59 (N386) were also designed with the intent of confirming the presence of cps genes distinct from the 79 documented capsular types ( Fig. 1B ; also see Table S1 in the supplemental material). In parallel with PCR for strain N386, cps PCR genotyping using the same primers was performed with 77 K-serotype reference strains (Statens Serum Institute), KN1 (A1517), and KN2 (can0507/1790N). PCR for 23S rDNA was used as a control to confirm that the DNA was amplifiable. K62 and KN3 strains were confirmed with a K62-specific capsule depolymerase and a KN3-specific capsule depolymerase, respectively, KN2 strains were confirmed with KN2 phage and the wzy PCR (28) , and K28 strains were confirmed with a K28 phage (our unpublished data).
K64 phage isolation. Phages that infected K64 K. pneumoniae strains were isolated from untreated water (termed K64-1) (28) . K. pneumoniae strains were cocultured with untreated water in LB broth overnight. After centrifugation, the supernatant was filtered with a 0.45-m-pore-size filter and was spotted on LB plates overlaid with K. pneumoniae to detect phage plaques. An agar overlay method was used for isolation of a pure phage preparation and for phage titer determination (41) .
Host ranges of phages. Host ranges of the isolated phages were determined by spot tests (28) . Briefly, LB agar plates were overlaid with top agar The primer pair of K64-wzyF and K64-wzyR was used for K64 cps PCR genotyping, and the primer pair of N386-wzyF and N386-wzyR was used for KN3 cps PCR genotyping.
inoculated with 200 l of fresh bacterial cultures of K. pneumoniae reference strains. One microliter of phage was spotted on the plate after the top agar with plating bacteria solidified. After 6 to 8 h, plaques were observed when the host was permissive for the phage infection.
Phage genomic DNA sequencing. Phage genomic DNA was extracted with a Qiagen Lambda kit (Qiagen, Valencia, CA). After phages were precipitated and lysed, the phage DNA was extracted with phenol-chloroform and then precipitated with ethanol. Genomic sequencing was performed by high-throughput sequencing (Yang-Ming Genome Research Center) using the Illumina/Solexa GAII sequencing platform, with the processing and assembly methods described below. Fifty nanograms of DNA was used to construct a sequencing library by using an Illuminacompatible Nextera DNA sample preparation kit (Epicentre), according to the manufacturer's instructions. The constructed library was quantified with quantitative PCR, and the library size was determined with a 2100 Bioanalyzer (Agilent) with a high-sensitivity DNA chip. Sequencing was performed by paired-end sequencing, with a 100-bp read length, with a HiSeq 2000 sequencing system (Illumina) at the Genome Research Center of National Yang-Ming University. The sequencing reads were trimmed for quality lower than Q20 and adapters, followed by de novo assembling with CLC Genomics Workbench (CLC bio, Aarhus, Denmark). Coding sequences were further predicted by Vector NTI and annotated by NCBI protein BLAST.
Capsule depolymerase expression and purification. The putative capsule depolymerase-encoding gene (K64dep) was cloned into a pET28c plasmid (Novagen, Madison, WI) with a His tag. Primers used for cloning are described in Table S1 in the supplemental material. The resulting plasmid was transformed into an E. coli BL21(DE3) strain. The recombinant His-tagged protein was expressed with 0.1 mM isopropyl-␤-D-thiogalactopyranoside (IPTG) induction at 25°C for 4 h and then was purified with nickel beads, according to the manufacturer's instructions (Qiagen) (28) .
Detection of endotoxin. The Limulus amebocyte lysate (LAL) Kinetic-QCL assay was used to detect endotoxin in purified protein preparations. Reagents were purchased from the Lonza Group, Ltd. (Walkersville, MD), and an ELx808LBS absorbance plate reader (Lonza) was used for detection.
Alcian blue staining. Extracellular polysaccharides (containing both capsule and lipopolysaccharide) were extracted with hot phenol, as reported previously (42) . The extracted material was incubated for 1 h at 37°C, with or without purified enzyme, and then capsular polysaccharide (CPS) was detected with Alcian blue, as described previously (40) .
Serum resistance assay. The K. pneumoniae serum resistance assay was performed as described previously (43) . A total of 10 8 CFU bacteria was pretreated for 1 h at 37°C with or without K64 capsule depolymerase at a final concentration of 100 g/ml. Then an inoculum of 2.5 ϫ 10 4 CFU bacteria was mixed with human serum from healthy volunteers at a volume ratio of 1:3. The mixture was incubated for 1 h at 37°C.
Neutrophil killing assay. The neutrophil killing assay was performed as described previously (44) . Briefly, human neutrophils were freshly isolated from peripheral blood donated by healthy volunteers (43) . An inoculum containing 10 5 CFU of bacteria (KCR2A), pretreated for 1 h at 37°C with or without K64 capsule depolymerase at a final concentration of 100 g/ml, was opsonized with 25% normal human serum on ice for 15 min and was incubated with 10 6 human neutrophils at 37°C for 45 min. Percent survival of depolymerase-treated or untreated bacteria was calculated based on viable counts relative to controls without depolymerase and neutrophils.
Animal inoculation and capsule depolymerase treatment. The animal protocol was approved by the Animal Care and Use Committee of NTUH. Five-week-old female BALB/cByl mice were treated with cyclophosphamide at a dose of 100 mg/kg, at 2-day intervals, by intraperitoneal injection. Three days after the second injection of cyclophosphamide, mice were infected with 6 ϫ 10 6 CFU of a K64 K. pneumoniae strain (KCR2A) administered intraperitoneally. One hour, 8 h, or 24 h after the bacterial challenge, the enzyme treatment group was given 150 g, 37.5 g, or 18.75 g purified K64dep protein by intraperitoneal injection (8 mice in each group). The enzyme-treated and untreated groups were monitored for 30 days. The rates of survival were compared and analyzed with the Kaplan-Meier method.
Acute toxicity. For the acute toxicity study, 150 g purified K64dep protein was administered intraperitoneally to normal mice or cyclophosphamide-treated mice (inoculated as described above). After 24 h, one group of mice was sacrificed for blood biochemical analyses and histopathological examinations, whereas the development of abnormal behavior and changes in physical appearance (such as symptoms of hunching and irregular breathing) were observed and the weights of the mice were recorded for 14 days in another group of mice.
Blood biochemical assays. Serum was obtained by centrifugation of whole blood at 3,000 ϫ g for 15 min. Serum levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT), and albumin (ALB) were measured to evaluate the liver function of the mice. Blood urea nitrogen (BUN) and creatinine (Cr) levels were determined for assessment of nephrotoxicity. Cell membrane injury and tissue damage were also evaluated, based on lactate dehydrogenase (LDH) measurements. These biochemical parameters were determined with an Hitachi 7080 biochemical analyzer (Hitachi, Japan).
Histopathological examinations. The livers, spleens, and kidneys were harvested, fixed in 10% formalin, embedded in paraffin, sectioned, and stained with hematoxylin and eosin for histological examinations.
Nucleotide sequence accession numbers. The KN2 wzc CD1-VR2-CD2 DNA sequence was submitted to GenBank with accession number AB986250. The sequences of the cps region of the K64 reference strain and the N386 strain (KN3) were submitted to GenBank with accession numbers AB897511 and AB897512, respectively. The genome of the multihost K. pneumoniae bacteriophage K64-1 was submitted to GenBank with accession number AB897757. The gene K64dep (2,991 bp in length) was submitted to GenBank with accession number AB897513.
RESULTS

Capsular types of CRKP.
The capsular types of 85 CRKP strains were determined by wzc sequencing (40) , and the findings were confirmed by wzy PCR genotyping. Among the 85 strains, 81 strains corresponded to known capsular types (Ն96% DNA identity across the CD1-VR2-CD2 variable region of wzc), including 32 (38%) K64, 11 (13%) K62, 7 (8%) K24, 6 (7%) KN2, and 5 (6%) K28 (Table 1 ; also see Table S2 in the supplemental material). One strain (KCR72) exhibited 88% DNA identity to K52 wzc sequences, but it was subsequently confirmed to be not K52 by wzy genotyping using K52-specific primers (see Table S1 in the supplemental material). In contrast, this strain was positive by K15 wzy genotyping (40) (the K15 reference strain was acapsular and lacked the wzc gene, whereas this strain, KCR72, was capsulated, with evidence of positive string test results [43] ). Thus, this strain may possess the same cps as the parental K15 reference strain, and the wzc of this capsulated strain may represent the K15 type. The remaining three CRKP strains, KCR57, KCR58, and KCR59, possessed the same wzc sequences, which were distinct from those of 79 documented capsular types (Ͻ80% DNA identity). A phylogenetic tree of wzc sequences from the reference strains and CRKP strains was generated by the neighbor-joining method (see Fig. S1 in the supplemental material). The cps region from one of the three strains (KCR59) was resolved, and the variable region of the cps gene cluster was analyzed (Fig. 1B) . Specific primers N386-wzyF and N386-wzyR were designed based on the novel wzy sequence ( Fig. 1B ; also see Table S1 in the supplemental material); PCR genotyping with this primer pair provided detection only of the three strains with the same wzc sequences, and not any of the 79 documented capsular types (data not shown). Phage specificity also confirmed this new type, because we have isolated a total of 79 bacteriophages infecting different capsular types of reported reference strains, KN1, and KN2 (our unpublished data), and none of them can infect the three strains (data not shown). Based on these results, we infer that the three strains likely belong to a new capsular type, named KN3.
Prevalence of carbapenemase genes. The prevalence of carbapenemase genes (bla IMP , bla VIM , bla KPC , bla , and bla NDM-1 ) in these CRKP strains was investigated by PCR. Of 85 CRKP strains, 10 isolates (12%) were positive for carbapenemase genes. The positive rates for bla IMP , bla KPC , and bla VIM were 6/85 strains (7%), 3/85 strains (4%), and 1/85 strains (1%), respectively, whereas none of the strains possessed bla OXA-48 or bla NDM-1 . The carbapenemase activity of these isolates was assessed by the Carba NP test. All of the 10 strains that possessed genes encoding carbapenemases (bla IMP , bla VIM , or bla KPC ) displayed positive reactions (turned from red to yellow), whereas the remaining strains showed negative results (Table 1 and data not shown).
Integron prevalence in CRKP. Integrons are a type of mobile genetic elements thought to be associated with antibiotic resistance, and class 1 integrons were found to be the most common type of integrons in Enterobacteriaceae (45) . Therefore, the presence of class 1 integrons in the 85 CRKP strains was investigated. The results showed that class 1 integrons were detected in 73% of CRKP strains (62/85 strains) ( Table 1 ). The integrons carried drug resistance genes such as dihydrofolate reductase genes (dhfr) conferring trimethoprim resistance, gene cassettes associated with resistance to aminoglycosides, including aminoglycoside acetyltransferase genes [aac(6=)-Iq, aac(6=)-Ib-cr, and aac(6=)-Ib] and aminoglycoside adenylyltransferase genes (aadA1, aadA2, and aadA5), streptothricin acetyltransferase gene (sat), chloramphenicol acetyltransferase genes (cat), rifampin ADP-ribosyl transferase gene (arr), and ␤-lactamase oxacillinase 1 (bla OXA-1 ) and oxacillinase 10 (bla OXA-10 ) genes. Moreover, integrons carrying the carbapenemase gene bla VIM-1 were also found (see Table S3 in the supplemental material).
CRKP sequence types. The sequence types (STs) of all 85 CRKP strains were determined (Table 1 ; also see Table S3 in the supplemental material). Strains with new MLST profiles were submitted to the Institut Pasteur MLST and whole-genome MLST databases (http://bigsdb.web.pasteur.fr) and were assigned to new STs (ST1711 to ST1720). ST11, which accounted for 47% of these CRKP strains (40/85 strains), was the major ST, whereas other sequence types each accounted for less than 10% of CRKP strains. ST11 was also predominant in some capsular types, such as K64 (28/32 strains), K62 (5/11 strains), and KN2 (5/6 strains).
Pulsed-field gel electrophoresis patterns of CRKP strains. We further investigated the genetic diversity of 13 CRKP strains on the basis of their PFGE patterns, to examine the relationships between capsular types, STs, and pulsotypes. We randomly selected 4 ST11 (major ST) strains and 4 non-ST11 strains for K64 capsular types and 3 ST11 strains for three other capsular types (K62, KN2, and K15). In addition, two non-ST11 strains for K62 and KN2 were included for comparison. Strains with differences of fewer than 3 fragments were assigned to the same pulsotypes (similarities of Ն70%). The results revealed that strains with the same ST may belong to different pulsotypes (see Fig. S2 , lanes 1 to 4, 9, 11, and 13, in the supplemental material). Conversely, strains designated as the same pulsotype may exhibit different STs (see Fig. S2, lanes 3, 6, 7 , and 8, in the supplemental material), either related (e.g., ST11 and ST859 differed only in their tonB alleles) or widely different (e.g., the alleles of the seven MLST genes were all different in ST11 and ST247). In addition, strains of the same ST 
a Genes encoding carbapenemases imipenemase, VIM (Verona integron-encoded metallo-␤-lactamase), KPC (Klebsiella pneumoniae carbapenemase), OXA-48 (oxacillinase 48), or NDM-1 (New Delhi metallo-␤-lactamase 1) were detected by PCR.
that belonged to different capsular types exhibited diverse PFGE patterns (see Fig. S2 , lanes 1, 9, 11, and 13, in the supplemental material). PFGE profiles indicated that some strains appeared to be closely related (differences of fewer than 3 fragments) and others showed differences in more than 3 bands (similarities of Ͻ70%) or even seven or more bands. The genetic diversity indicates that CRKP strains were not genetically identical clones. K64 bacteriophage isolation and capsule depolymerase identification. A multihost K. pneumoniae bacteriophage, K64-1, which can infect K1, K11, K21, K25, K30, K35, K64, and K69 reference strains, was isolated. Phage genome sequences were resolved by high-throughput sequencing. The genome was 346,602 bp in length, and genes were further annotated with NCBI protein BLAST. Multiple putative capsule depolymerase-encoding genes were identified (our unpublished data), and one of these genes was shown to encode a K64-specific depolymerase, as follows. The K64dep gene (2,991 bp in length), located at nucleotides 338917 to 341907 of the K64-1 genome, was cloned and expressed with the His tag. Purified protein was spotted on LB agar plates with the phage hosts. After overnight incubation at 37°C, a semi-clear zone was formed on K64 bacteria (Fig. 2) , indicating that the gene (termed K64dep) encodes a K64 capsule depolymerase. K64dep could digest only capsules from strains of the K64 capsular type (including the K64 reference strain and 6 clinical strains) and not the 78 non-K64 reference strains (data not shown).
Alcian blue staining of enzyme-digested CPS. The capsuledegrading property of K64dep was further validated by Alcian blue staining of enzyme-treated CPS. Our results revealed that enzyme-free CPS showed high-molecular weight capsular polysaccharide polymers at the top of an SDS-PAGE gel, whereas lower-molecular weight material was observed when CPS was treated with 5 g of enzyme (Fig. 3) .
Serum sensitivity of enzyme-treated bacteria. The effects of serum killing after enzyme treatment were assessed in a carbapenem-resistant K64 strain, KCR2A. After incubation with serum for 1 h, almost all of the bacteria were killed by 75% serum when the bacteria were pretreated with K64dep (Fig. 4) , whereas the bacterial load was moderately decreased to about 40% of the initial inoculum in control samples. Compared to control samples, which can proliferate with 10% and 25% serum, the enzymetreated bacteria were sensitive to serum killing (Fig. 4) . Thus, the capsule depolymerase can enhance bacterial susceptibility to serum killing.
Neutrophil killing of enzyme-treated bacteria. Neutrophilmediated killing of the K64 strain KCR2A, with or without enzyme treatment, was examined. Compared to untreated controls, the numbers of bacteria pretreated with K64dep enzyme were significantly decreased after incubation with human neutrophils, reference strain was grown on a LB plate. Phage (10 6 PFU) or various amounts of capsule depolymerase were spotted on the plate, and plaque or a semi-clear zone, respectively, was observed. The amounts of enzyme used are shown in parentheses.
FIG 3 Alcian blue staining of CPS treated with K64 capsule depolymerase.
Polysaccharide extracts from the K64 reference strain and a carbapenem-resistant K64 strain, KCR2A, were treated with 5 g K64dep and stained with Alcian blue (see Materials and Methods). Lane M, protein markers.
FIG 4
Survival of enzyme-treated bacteria with serum killing. Bacterial susceptibility to killing by human serum for a carbapenem-resistant K64 strain, KCR2A, with or without enzyme (enz) pretreatment, is presented. Survival ratio, percent survival of bacteria after a 1-h incubation with serum (viable counts relative to the initial inoculum). Three independent experiments were performed, and the survival rates of the two groups (control and enzyme pretreated) were compared by Student's t test (75% serum, P ϭ 0.0002; 25% serum, P ϭ 0.0018; 10% serum, P Ͻ 0.0001). ‫,ءء‬ P Ͻ 0.01; ‫,ءءء‬ P Ͻ 0.001.
suggesting that enzyme treatment makes bacteria more susceptible to neutrophil killing (P ϭ 0.0004, t test) (Fig. 5) .
Capsule depolymerase treatment in K. pneumoniae-infected mice. Since K64 strains were less virulent than strains causing community-acquired pyogenic liver abscess (PLA) (for example, the 50% lethal dose [LD 50 ] of NTUH-K2044 for mice was ϳ1 ϫ 10 3 CFU [20] ) and exhibited very high lethal doses (LD 50 of 3 ϫ 10 7 CFU), we assessed the therapeutic effect of capsule depolymerase in mice treated with cyclophosphamide, which reduces the numbers of white blood cells in mice (20) . The results showed that 6 of the 8 mice infected with 6 ϫ 10 6 CFU of a CRKP K64 strain (KCR2A) died within 2 days without enzyme treatment. In contrast, infected mice treated with various amounts of enzyme at 1 h postinfection all survived and appeared to be healthy after 30 days. Statistical analysis of survival rates revealed that enzyme treatment was therapeutic for MDRKP infections (P ϭ 0.0029, log-rank test). However, the enzyme became therapeutically ineffective when it was administered 8 h postinfection (P ϭ 0.09, log-rank test) (Fig. 6) .
Acute toxicity study. The amounts of endotoxin in purified protein preparations were determined with K64dep levels of 9 endotoxin units (EU)/mg. In order to evaluate the acute toxicity caused by enzyme injection, blood biochemical analyses and histopathological examinations were conducted with the following four groups: normal mice, normal mice treated with enzyme (150 g), cyclophosphamide-treated mice, and cyclophosphamidetreated mice treated with enzyme. Analysis of variance (ANOVA) showed that there were no differences in serum levels of AST, ALT, ALB, BUN, Cr, and LDH between the four groups 24 h after enzyme treatment (see Fig. S3 in the supplemental material) . Livers, spleens, and kidneys did not show significant histopathological changes in the enzyme-treated mice (see Fig. S4 in the supplemental material). In addition, during the 14-day observation period, no obvious differences in weight gain were found between the control and enzyme-treated groups (data not shown), and no development of abnormal behavior, changes in physical appearance, or any other adverse reactions were observed. Therefore, enzyme treatment did not cause toxicity in mice.
DISCUSSION
K. pneumoniae causes hospital-acquired infections (1) as well as community-acquired pneumonia (2) and pyogenic liver abscess (PLA) (3). The capsule has been regarded as a major virulence factor of K. pneumoniae, and capsular types are related to the clinical manifestation of infections (43, 46) . The prevalence of capsular types in clinical settings of community-acquired infections, such as PLA (29, 47, 48) and pneumonia (2), was relatively clear, while types in hospital-acquired infections remained unclear, due to the limitations of traditional serotyping (ϳ25% were typeable) (21, 49, 50) . K1 and K2 were the predominant capsular types of PLA strains (60 to 85%) (47) and pneumonia strains (53%) (2) . Nevertheless, capsular types of CRKP were rarely documented, because CRKP studies focused in hospital-acquired infections. A recent report that directly resolved the CPS structures of two CRKP outbreak isolates and characterized them as a new type also noted that difficulties in serotyping could be the reason for the unavailability of serotype data for CRKP (22) . Subsequently, the new capsular type (cpsBO-4-like) was reported to be predominant in K. pneumoniae carbapenemase (KPC)-producing K. pneumoniae strains (38/46 strains [82.6%]) and the other new capsular type (cps207-2-like) accounted for 17.4% of the 46 CRKP
FIG 5
Neutrophil-mediated killing of enzyme-treated bacteria. Bacterial susceptibilities to killing by human neutrophils with or without enzyme pretreatment were compared. The percent survival of depolymerase-treated or untreated bacteria was calculated based on viable counts relative to controls without depolymerase and neutrophils (P ϭ 0.0004, t test).
FIG 6
Capsule depolymerase treatment in carbapenem-resistant K. pneumoniae-infected mice. BALB/cByl mice were infected with 6 ϫ 10 6 CFU bacteria and treated with various amounts of enzyme at different postinfection times (8 mice in each group). The results of 18.75-g enzyme treatment 1 h after bacterial challenge and 150-g enzyme treatment 8 h after bacterial challenge are shown. The x axis represents days after inoculation, and the y axis represents the survival rate of the mice. Statistical analysis was performed using the Kaplan-Meier method (P ϭ 0.0029 for control versus 1-h treatment with 18.75 g enzyme; P ϭ 0.09 for 8-h treatment, log-rank test).
strains from a collection of K. pneumoniae clinical isolates in Italy (23) . The two new types were also considered to be major types in epidemic KPC-producing K. pneumoniae ST258 strains in the United States (25) (26) (27) . Another study documented that most of the CRKP strains from New York were assigned to a ST258 clone by multilocus sequence typing (MLST) (32/40 strains [80%]), but capsular types were not well defined and several novel C-patterns of cps synthesis regions were identified (24, 51) .
Here we determined the capsular types of CRKP in Taiwan using wzc sequencing and confirmed the findings with wzy PCR or phage-depolymerase specificity assays. K64, which accounted for 32/85 CRKP strains (38%), was the most prevalent type. K62 was the second most common type (11/85 strains [13%]), followed by K24 (7/85 strains [8%]), KN2 (6/85 strains [7%]), and K28 (5/85 strains [6%]). These 5 capsular types accounted for 72% of CRKP strains (61/85 strains). Intriguingly, although K1 and K2 seem to be the most common capsular types causing PLA or pneumonia, there was no K1 strain and only one K2 strain among the CRKP isolates. The results indicated that MDRKP (mostly from nosocomial infections) showed different patterns of capsular types than community-acquired isolates. Similar observations were noted in a report (21) that indicated that isolation of the K1 serotype in community-acquired infections was higher than in nosocomial infections (30% versus 14%). Therefore, our important finding of the clustering of capsular types in CRKP could be an important basis for development of capsule-based vaccines and phage-depolymerase treatments. In addition, three of the CRKP strains could belong to a new capsular type, according to their novel wzc sequences (40) . We further resolved the cps region of the type and found that its cps sequences were distinct from those of 79 existing capsular types and the reported predominant two new types of KPC-producing strains from Italy and the United States (the wzc alleles of the previously reported two types did not match any reference or currently resolved wzc sequences, i.e., Ͻ80% DNA identity) (23, (25) (26) (27) . Moreover, the results from the current study indicate that wzc sequencing is a useful method for capsular genotyping.
To examine the genetic diversity and relationships among the CRKP strains, STs, pulsotypes, and the sequences of various genetic loci were determined (see Table S3 in the supplemental material). Previous studies reported that ST258 is a major clone throughout the world (23, 24, 52) , and a single-locus variant of ST258, ST11, was considered to be predominant in ESBL-producing strains in Asia (53, 54) and was prevalent in CRKP strains in Taiwan (55) . In the current study, ST11 was the major ST of these CRKP strains (40/85 strains [47%]), whereas other STs each accounted for less than 10% of CRKP strains. Moreover, ST11 was also predominant in some capsular types, such as K64 (28/32 strains), K62 (5/11 strains), and KN2 (5/6 strains).
PFGE analysis of 13 CRKP strains revealed that strains with the same ST may belong to different pulsotypes. Conversely, strains designated as the same pulsotype may exhibit different STs. In addition, strains with the same ST but different capsular types exhibited diverse PFGE patterns. We also found that, even when strains were assigned to the same ST and capsular type, there was obvious genomic heterogeneity (e.g., PFGE patterns, integrin-carrying genes, ␤-lactamases, and MICs) among the strains (see Table S3 in the supplemental material). The genetic diversity indicated that the collected strains were not from an outbreak of a single clone, and we suggest that carbapenem-resistant K. pneumoniae strains with capsular type K64 and ST11 may have increased epidemic potential that may be associated with resistance spread. In addition, our K64dep capsule depolymerase can digest K64 strains even if they have great genetic diversity (e.g., the pulsotypes of KCR9B and KCR5 are different from those of other K64 strains) (see Fig. S2 in the supplemental material). Therefore, CRKP isolates could be lysed by the current depolymerase due to capsule type specificity, not because of origination from genetically identical clones.
Since production of carbapenemases is one of the important mechanisms of carbapenem resistance, we detected five common carbapenemase genes (bla IMP , bla VIM , bla KPC , bla , and bla NDM-1 ) in these CRKP strains with a positive rate of ϳ12%, which is similar to previous reports (56) . We also assessed the carbapenemase activities of all of the CRKP strains, to investigate whether the remaining 88% of strains (PCR negative for reported carbapenemase genes) might possess new carbapenemases. According to the results, theses strains showed no carbapenemase activity. In addition, our PCR results indicated that most of the CRKP strains harbored SHV ESBLs or AmpC ␤-lactamase (DHA-1). Therefore, we suggested that the carbapenem resistance of the strains that did not harbor carbapenemases could be due to highlevel production of ESBLs or AmpC ␤-lactamase coupled with porin deficiency. Also, we cannot exclude another possible mechanism, i.e., overexpression of efflux pumps could confer carbapenem resistance (57) .
Mobile genetic elements such as plasmids, transposons, and integrons can facilitate the spread of antibiotic resistance genes among bacteria. Our results indicated that class 1 integrons were present in 73% of CRKP strains and most of them carried drug resistance genes. Moreover, integrons carrying bla VIM-1 (carbapenemase gene) were also found. Thereby, the carriage of integrons may contribute to the multidrug resistance of K. pneumoniae.
Previous studies reported that the virulence of K. pneumoniae was attenuated in capsule-deficient mutants (42, 43) , suggesting that the capsule is a major virulence factor of K. pneumoniae. On the other hand, it was proposed that bacteriophages can digest the capsule of encapsulated bacteria with capsule-degrading enzymes, which contributes to successful infection (58) . Therefore, we isolated the phage and also identified the capsule depolymerase degrading the capsule of the major type in CRKP strains, which could be used as therapeutic alternatives. NCBI BLAST results indicated that K64dep showed 30% amino acid identity (171/579 amino acids) with a putative tail fiber located at nucleotides 30856 to 33738 of Enterobacteriaceae phage (GenBank accession number NC_007603.1), and no matches were found in the protein family database Pfam. Similarly, no putative conserved domains or motifs were detected using the Simple Modular Architecture Research Tool (SMART). A comparison of K64dep and a recently identified K1 K. pneumoniae-specific capsule depolymerase (open reading frame 34 [ORF34]) also exhibited very low similarity, indicating that the capsule type-specific depolymerase could be unique. Therefore, the properties of this protein remain unclear and await further analyses (e.g., structure, enzymatic reactions, and final degradation products).
Removal of the histidine tag and traces of endotoxins will be ideal if human trials are considered. However, the current histidine-tag-containing K64dep protein revealed strong enzyme activity in vitro and in animal studies. In addition, no acute toxicity was observed in animals, although we did not remove the tag and endotoxin in the current study. The capsule-degrading property of K64dep was validated by Alcian blue staining of enzyme-treated CPS at low molecular weight. The difference between K64ref and KCR2A after enzyme treatment could be due to different CPS amounts from bacteria cultured overnight. The serum killing and neutrophil killing experiments indicated that capsule depolymerase could efficiently reduce the bacterial resistance against serum and neutrophils. Because K64 strains were less virulent than strains causing community-acquired pyogenic liver abscess and had very high lethal doses, a high dose of K. pneumoniae (6 ϫ 10 6 CFU) was given to mice. The results indicated that the therapeutic effect of capsule depolymerase in cyclophosphamide-treated mice was very significant, but capsule depolymerase was ineffective if administered 8 h postinfection. A possible reason could be too many bacteria after rapid proliferation in cyclophosphamidetreated mice. K64dep-producing phages or combination treatment might overcome this problem.
The toxicity study demonstrated that mice treated with 150 g of K64dep, which contained 1.36 EU of endotoxin (9 EU/mg K64dep), showed normal biochemical parameters (AST, ALT, ALB, BUN, Cr, and LDH levels) and no significant histopathological changes in liver, kidney, and spleen. Therefore, enzyme treatment did not cause toxicity in mice. However, for application in human therapy, endotoxin can be further removed and reduced to lower levels (ϳ0.2 EU/mg) using more effective methods, as described previously (59) . The efficacy and safety results indicated that the depolymerase could be an alternative therapy for MDRKP infections.
In conclusion, we reveal a clustering of CRKP capsular types and develop a depolymerase-based nonantibiotic treatment. Capsular type prevalence data could also facilitate the development of capsule-based vaccines for MDRKP.
